Published: Dec 24, 2020, 21:10 IST | Updated: Dec 24, 2020, 21:10 IST
The Indian vaccine against COVID-19 Covaxin is drawing some global attention. ICMR shares Covaxin Phase-2 trial results in which they mention that 'data generated within India underlines impressive safety'.